Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Primary Immunodeficiencies
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1444130

MicroRNA dysregulation in Ataxia Telangiectasia

Provisionally accepted
  • 1 Department of Translational Medical Sciences, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
  • 2 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Campania, Italy
  • 3 Institute for Calculation Applications Mauro Picone, Department of Engineering, ICT and Technology for Energy and Transport, National Research Council (CNR), Rome, Lazio, Italy
  • 4 Department of Translational Medical Sciences, Pediatric Section, Federico II University of Naples, Naples, Italy
  • 5 Department of Pediatrics, University of Naples Federico II, Naples, Italy
  • 6 Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Lombardy, Italy
  • 7 Pediatric Area, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
  • 8 Department of Internal Medicine, IRCCS Ca 'Granda Foundation Maggiore Policlinico Hospital, Milan, Lombardy, Italy
  • 9 Department of Pediatric Oncohematology, University Hospital of Parma, Parma, Emilia-Romagna, Italy
  • 10 Department of Public Health and Pediatric Sciences, School of Medicine, University of Turin, Turin, Piedmont, Italy
  • 11 Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
  • 12 Centro Regionale di Biologia Molecolare – Arpa Piemonte, Torino, Italy
  • 13 Department of Clinical and Biological Sciences, School of Medicine, University of Turin, Turin, Piedmont, Italy
  • 14 Istituto di Genetica Molecolare - Consiglio Nazionale delle Ricerche (CNR), Bologna, Italy
  • 15 Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
  • 16 Department of Neuroscience Rita Levi Montalcini, University of Turin, Turin, Piedmont, Italy
  • 17 Unità di Genetica Medica, AOU Città della Salute e della Scienza di Torino, Torino, Italy

The final, formatted version of the article will be published soon.

    Introduction: Ataxia Telangiectasia (AT) is a rare disorder characterized by neurodegeneration, combined immunodeficiency, a predisposition to malignancies and high clinical variability. Profiling of microRNAs (miRNAs) may offer insights into the underlying mechanisms of complex rare human diseases, as miRNA play a role in various biological functions including proliferation, differentiation, and DNA repair. In this study we investigate the differential expression of miRNAs in samples from AT patients with the aim of identifying miRNA patterns and to investigate how these patterns are related to the disease.We enrolled twenty AT patients (mean age 17.7+9.6 years old) and collected clinical and genetic data. We performed short non-coding RNA-seq analysis on peripheral blood mononuclear cells (PBMCs) and fibroblasts to compare the miRNA expression profile between AT patients and controls.We observed 42 differentially expressed (DE)-miRNAs in blood samples and 26 in fibroblasts samples. Among these, three were further validated in additional AT samples, confirming their dysregulation.We identified an AT-related miRNA signature in blood cells and fibroblast samples collected from a group of AT patients. We also predicted several dysregulated pathways, primarily related to cancer, immune system control or inflammatory processes. The findings suggest that miRNAs may provide insights into the pathophysiology and tumorigenesis of AT and have the potential to serve as useful biomarkers in cancer research.

    Keywords: Ataxia Telangiectasia, microRNA, immunodeficiency, Cancer, DNA Repair

    Received: 05 Jun 2024; Accepted: 29 Jul 2024.

    Copyright: © 2024 Cirillo, Tarallo, Toriello, Carissimo, Giardino, De Rosa, Damiano, Soresina, Badolato, Dellepiane, Baselli, Carrabba, Fabio, Bertolini, Montin, Conti, Romano, Pozzi, Ferrero, RONCARATI, Ferracin, Brusco, Parenti and Pignata. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Claudio Pignata, Department of Translational Medical Sciences, Pediatric Section, Federico II University of Naples, Naples, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.